3 Undervalued Pharmaceuticals Stocks for Monday, March 25
Discover the top 3 undervalued Pharmaceuticals stocks for Monday, March 25 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Commentary & Analysis
Is Akanda Corp (AKAN) Stock a Good Investment?
Learn more about Akanda Corp's (AKAN) stock grades for Growth and determine whether this Pharmaceuticals stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.7 | $470.3 | 3% |
|
| Shares Out (Mil) | 0.8 | 43.4 | 4% |
|
| Institutional Ownership | 1.1% | 81.3% | 2% |
|
| Float (Mil) | 0.5 | 46.8 | 1% |
|
| Beta | na | 0.71 | na |
|
| Avg Daily Volume (000s) | 654 | 279 | 63% |
|
| Price Change (52-week) |
(97.3%) | 54.1% | 3% |
|
| Growth | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.1% | na |
|
| Net Income (5yr) | (81.8%) | (2.4%) | 3% |
|
| EPS (5yr) | na | 14.9% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1 | $335 | 1% |
|
| Net Income (TTM) (Mil) | ($51) | ($11) | 16% |
|
| EPS (TTM) | ($64.961) | ($0.700) | 1% |
|
| Operating Cash Flow (TTM) (Mil) | ($10) | ($6) | 21% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $4 | 39% |
|
| Long-Term Debt (Q1) (Mil) | $10 | $6 | 29% |
|
| Enterprise Value (Q1) (Mil) | $18 | $493 | 11% |
|
| Valuation | AKAN | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.17 | na |
|
| P/E | na | 17.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (12.0%) | 69.4% | 3% |
|
| Net Margin | na | 3.3% | na |
|
| ROA | (806.9%) | (21.8%) | 0% |
|
| ROE | 856.6% | (21.0%) | 100% |
|
| Liabilities to Assets | 356.0% | 31.8% | 100% |
|
| F-Score | 1 | 3 | 1% |
|
Akanda Corp. did not pass any screens on 10/30/2026.
